Evolving Importance of Diffusion-Weighted Magnetic Resonance Imaging in Lymphoma - 14/02/12
Doi : 10.1016/j.cpet.2011.11.001
Thomas C. Kwee, MD, PhD a, ⁎ 
, Sandip Basu, MBBS (Hons), DRM, DNB b, c, Drew A. Torigian, MD, MA c, Rutger A.J. Nievelstein, MD, PhD a, Abass Alavi, MD, PhD (Hon), DSc (Hon) d
, Sandip Basu, MBBS (Hons), DRM, DNB b, c, Drew A. Torigian, MD, MA c, Rutger A.J. Nievelstein, MD, PhD a, Abass Alavi, MD, PhD (Hon), DSc (Hon) d a Department of Radiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
b Radiation Medicine Center (Bhabha Atomic Research Center), Tata Memorial Center Annexe, Jerbai Wadia Road, Parel, Mumbai 400012, Maharashtra, India
c Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19102, USA
d Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19102, USA
Corresponding author.Résumé |
Diffusion-weighted magnetic resonance imaging (DWI) is a rapidly evolving functional imaging modality that can now be used for the evaluation of lymphomatous lesions throughout the body. This article describes the basics of (whole-body) DWI, and reviews and discusses the evolving importance of whole-body DWI for the staging and therapy response assessment of lymphoma.
Le texte complet de cet article est disponible en PDF.Keywords : Diffusion-weighted imaging, Magnetic resonance imaging, Whole-body imaging, Lymphoma, Hodgkin, Non-Hodgkin
Plan
© 2012
Elsevier Inc. Tous droits réservés.
Vol 7 - N° 1
P. 73-82 - janvier 2012 Retour au numéro
Article précédent
- The Use of PET in Radiation Therapy for Lymphoma
- John P. Plastaras, Geoffrey Geiger, Rodolfo Perini, Eli Glatstein
- Novel PET Radiotracers for Potential Use in Management of Lymphoma
- Lale Kostakoglu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?